"Poradnia zaburzeń pamięci"

During the past decade, Wroclawskie Centrum Alzheimerowskie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wroclawskie Centrum Alzheimerowskie" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wroclawskie Centrum Alzheimerowskie" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (1 trials), "Alzheimer´s Disease" (1 trials), "Brain Diseases" (1 trials) and "Central Nervous System Diseases" (1 trials). Many other conditions were trialed in "Wroclawskie Centrum Alzheimerowskie" in a lesser frequency.

Most popular intervention types in "Wroclawskie Centrum Alzheimerowskie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Donanemab" (2 trials), "Lanabecestat" (2 trials) and "LY3372689" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wroclawskie Centrum Alzheimerowskie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Wroclawskie Centrum Alzheimerowskie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Wroclawskie Centrum Alzheimerowskie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wroclawskie Centrum Alzheimerowskie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".